CCR5 and plasma cell myeloma: CCR5 contributes to tumor progression in several hematological cancers, including acute lymphoblastic leukemia [39], acute myeloid leukemia, chronic myeloid leukemia [83], classic Hodgkin lymphoma [38], and multiple myeloma [84].